Uncontrolled Substances, Part 4: The Reckoning
Dec 22, 2022•26 min•Transcript available on Metacast Episode description
Two years after launching, Cerebral had become a star in the telemedicine business space. The company had attracted tens of thousands of patients and was valued at close to $5 billion. CEO Kyle Robertson had big plans for the startup, but this spring, those plans started to crumble. WSJ’s Rolfe Winkler and Khadeeja Safdar started reporting on Cerebral. Their reporting would lead to federal investigations and major changes for the company.
Further Reading:
- The Failed Promise of Online Mental-Health Treatment
Further Listening:
- The Journal: Uncontrolled Substances, Part 1: Subscribe and Prescribe
- The Journal: Uncontrolled Substances, Part 2: Adderall
- The Journal: Uncontrolled Substances, Part 3: Anthony
Learn more about your ad choices. Visit megaphone.fm/adchoices
